Medindia

X

Pharmacyclics Announces Oral Presentation and Material Clinical Update at the 2010 Annual Meeting of the American Society of Clinical Oncology

Friday, May 21, 2010 General News J E 4
Advertisement

Title: 'Btk inhibitor PCI-32765 monotherapy induces objective responses in patients with relapsed aggressive NHL: Evidence of antitumor activity from a phase I study'

Date: Saturday, June 5, 2010,

Time:  3:45 PM Central Time

Location:  Room E354a (McCormick Place) Permanent Abstract ID 8012

Primary presenter: Dr. Nathan Fowler, MD Anderson Cancer Center

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Dendreon Announces Presentation of PROVENGE Data a...
S
Genomic Health Announces Six New Studies Including...